CIBOX INTER@CTIVE (CIB.PA) Fundamental Analysis & Valuation

EPA:CIB • FR0000054322

Current stock price

0.0615 EUR
-0.01 (-10.74%)
Last:

This CIB.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CIB.PA Profitability Analysis

1.1 Basic Checks

  • In the past year CIB has reported negative net income.
CIB.PA Yearly Net Income VS EBIT VS OCF VS FCFCIB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 500K -500K -1M

1.2 Ratios

Industry RankSector Rank
ROA -2.03%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CIB.PA Yearly ROA, ROE, ROICCIB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 5 -5 10 15 20

1.3 Margins

Industry RankSector Rank
OM -0.23%
PM (TTM) -1.93%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CIB.PA Yearly Profit, Operating, Gross MarginsCIB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CIB.PA Health Analysis

2.1 Basic Checks

  • CIB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CIB has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for CIB has been reduced compared to a year ago.
CIB.PA Yearly Shares OutstandingCIB.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
CIB.PA Yearly Total Debt VS Total AssetsCIB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 5M 10M 15M

2.2 Solvency

  • CIB has an Altman-Z score of 2.00. This is not the best score and indicates that CIB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CIB has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 2
ROIC/WACCN/A
WACC7.21%
CIB.PA Yearly LT Debt VS Equity VS FCFCIB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 2M 4M

2.3 Liquidity

  • CIB has a Current Ratio of 1.80. This is a normal value and indicates that CIB is financially healthy and should not expect problems in meeting its short term obligations.
  • A Quick Ratio of 1.64 indicates that CIB should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.64
CIB.PA Yearly Current Assets VS Current LiabilitesCIB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. CIB.PA Growth Analysis

3.1 Past

  • CIB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -142.98%.
  • CIB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.52%.
  • CIB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.86% yearly.
EPS 1Y (TTM)-142.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-78.37%
Revenue 1Y (TTM)10.52%
Revenue growth 3Y12.58%
Revenue growth 5Y0.86%
Sales Q2Q%40.28%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CIB.PA Yearly Revenue VS EstimatesCIB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M

More info and screens

Find the best growth stocksShow best growing peers

0

4. CIB.PA Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CIB.PA Price Earnings VS Forward Price EarningsCIB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.87
CIB.PA Per share dataCIB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CIB.PA Dividend Analysis

5.1 Amount

  • CIB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CIB.PA Fundamentals: All Metrics, Ratios and Statistics

CIBOX INTER@CTIVE

EPA:CIB (9/29/2022, 7:00:00 PM)

0.0615

-0.01 (-10.74%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.86M
Revenue(TTM)16.04M
Net Income(TTM)-309.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.43
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB N/A
EV/EBITDA 22.87
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.14
BVpS0.05
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.23%
PM (TTM) -1.93%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.64
Altman-Z 2
F-Score1
WACC7.21%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-142.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-78.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.52%
Revenue growth 3Y12.58%
Revenue growth 5Y0.86%
Sales Q2Q%40.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CIBOX INTER@CTIVE / CIB.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CIBOX INTER@CTIVE (CIB.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CIB.PA.


What is the valuation status for CIB stock?

ChartMill assigns a valuation rating of 0 / 10 to CIBOX INTER@CTIVE (CIB.PA). This can be considered as Overvalued.


Can you provide the profitability details for CIBOX INTER@CTIVE?

CIBOX INTER@CTIVE (CIB.PA) has a profitability rating of 0 / 10.


Can you provide the financial health for CIB stock?

The financial health rating of CIBOX INTER@CTIVE (CIB.PA) is 4 / 10.